JENNA DEAN: Open Payments
NPI 1720791577 · LINCOLN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 23 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $237 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Corcept Therapeutics | 3 | $52 |
| Novo Nordisk Inc | 2 | $37 |
| Insulet Corporation | 1 | $31 |
| Recor Medical Inc | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: REPATHA, LEQVIO, Korlym, Omnipod, Paradise Ultrasound Renal Denervation System, NEXLETOL, CRENESSITY, ISTURISA.
Industry payments across IL — which companies pay providers there.
